The rollbacks in clean energy incentives in Republicans' budget plans will put the brakes on U.S. greenhouse gas emissions reductions by throttling the growth of renewables and electric vehicles.
This case carries with it the weight of fierce scientific and policy debates about the safety, efficacy, and propriety of medical treatments in an evolving field. The voices in these debates raise sincere concerns; the implications for all are profound. The Equal Protection Clause does not resolve these disagreements. Nor does it afford us license to decide them as we see best.